MedPath

OPVEE

These highlights do not include all the information needed to use OPVEE safely and effectively. See full prescribing information for OPVEE. OPVEE (nalmefene) nasal spray Initial U.S. Approval: 1995

Approved
Approval ID

999a4269-9e54-4801-b2ac-2a7276f0b94f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 20, 2023

Manufacturers
FDA

Indivior Inc.

DUNS: 797408549

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

nalmefene hydrochloride

PRODUCT DETAILS

NDC Product Code12496-0003
Application NumberNDA217470
Marketing CategoryC73594
Route of AdministrationNASAL
Effective DateNovember 20, 2023
Generic Namenalmefene hydrochloride

INGREDIENTS (1)

nalmefene hydrochlorideActive
Quantity: 2.7 mg in 100 uL
Code: K7K69QC05X
Classification: ACTIM
© Copyright 2025. All Rights Reserved by MedPath
OPVEE - FDA Approval | MedPath